Beryllium Quantitative, Serum or Plasma
Also known as: BERYLLI SP
Use
This test is used to confirm exposure to beryllium but is not useful for determining the time since exposure or the extent of exposure. For a more reliable indicator of beryllium sensitization and/or chronic beryllium disease (CBD), refer to the Beryllium Lymphocyte Proliferation, Blood (2011052) test.
Special Instructions
Specimens for elemental testing should be collected in certified metal-free containers. Elevated results may be caused by environmental contamination during specimen collection and should be interpreted accordingly. It is recommended to verify unexpected elevated results by testing another specimen in a trace metal-free container.
Limitations
This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration. It is performed by a non-ARUP laboratory, and separate specimens must be submitted when multiple tests are ordered.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 5594-7
Result Turnaround Time
8-11 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2 mL
Minimum Volume
0.6 mL
Container
Acid Washed Transport Vial
Collection Instructions
Collect specimen in a Royal Blue (no additive) or Royal Blue (EDTA) tube. Separate from cells ASAP or within 2 hours of collection.
Storage Instructions
Refrigerated. Also acceptable: Room temperature or frozen.
Causes for Rejection
Separator tubes.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 2 weeks |
| Refrigerated | 2 weeks |
| Frozen | 2 weeks |